Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Review

Published on 24 Nov 2022

The research progress of anti-inflammatory and anti-fibrosis treatment of chronic pancreatitis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Bing-Qing Li
Xin-Yuan Liu
Tao Mao
Tao-Hua Zheng
Peng Zhang
Qi Zhang
Yu Zhang
Xiao-Yu Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1050274

4,053 views
6 citations

Original Research

Published on 24 Nov 2022

Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yong Yi
Bao-Ye Sun
Jia-Lei Weng
Cheng Zhou
Chen-Hao Zhou
Ming-Hao Cai
Jing-Yun Zhang
Hong Gao
Jian Sun
Jian Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1046584

3,588 views
25 citations

Original Research

Published on 24 Nov 2022

Establishment and validation of a prognostic nomogram for extrahepatic cholangiocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Fangrui Zhao
Dashuai Yang
Jiahui He
Xianli Ju
Youming Ding
Xiangpan Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1007538

2,299 views
4 citations

Methods

Published on 24 Nov 2022

Safety and efficacy of radiotherapy combined with lenvatinib plus PD-1 inhibitors as neo-adjuvant therapy in hepatocellular carcinoma with portal vein thrombus: protocol of an open-label, single-arm, prospective, multi-center phase I trial

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Guangxin Li
Bin Shu
Zhuozhao Zheng
Hongfang Yin
Chen Zhang
Ying Xiao
Yanmei Yang
Zhe Yan
Xiaofei Zhang
Shizhong Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1051916

4,138 views
5 citations

Review

Published on 24 Nov 2022

The role of tumor microenvironment reprogramming in primary liver cancer chemotherapy resistance

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Chunyu Zhao
Shanshuo Liu
Feng Gao
Yawen Zou
Zhigang Ren
Zujiang Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.1008902

3,713 views
12 citations

Original Research

Published on 23 Nov 2022

Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qing Li
Zhenyu Chang
Tianyi Wang
Bing Liu
Ximin Wang
Xin-Yu Ge
Tao Yang
Qu Liu
Wei Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.989080

1,890 views
1 citation

Case Report

Published on 23 Nov 2022

Encouraging efficacy of a comprehensive therapy consisting of sintilimab, bevacizumab biosimilar IBI305, hypo-fractionated intensity-modulated radiotherapy, and oxaliplatin for a maxillary metastasis from hepatocellular carcinoma: A case report and literature review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xuexia Liang
Qiaodan Liu
Wei Yao
Shuqin Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.941454

1,857 views
1 citation

Review

Published on 22 Nov 2022

Systemic therapies in hepatocellular carcinoma: Existing and emerging biomarkers for treatment response

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Penghui He
Haifeng Wan
Juan Wan
Hanyu Jiang
Yu Yang
Kunlin Xie
Hong Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.1015527

3,157 views
7 citations

Original Research

Published on 22 Nov 2022

Lenvatinib as second-line treatment in patients with unresectable hepatocellular carcinoma: A retrospective analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

He-nan Qin
Zhen Ning
Rui Sun
Chen-xing Jin
Xin Guo
A-man Wang
Ji-wei Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1003426

5,352 views
5 citations

Original Research

Published on 22 Nov 2022

Integrated systemic analysis of FAM72A to identify its clinical relevance, biological function, and relationship to drug sensitivity in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qi Zhou
Lingjun Chen
Luo Yang
Haoxiong Zhou
Yan Chen
Yunwei Guo

Frontiers in Oncology

doi 10.3389/fonc.2022.1046473

3,352 views
3 citations

Review

Published on 22 Nov 2022

Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Shilun Wu
Zhuxin Li
Changyu Yao
Shuying Dong
Jun Gao
Shan Ke
Ruhang Zhu
Sen Huang
Shaohong Wang
Li Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.1032746

4,188 views
11 citations

Review

Published on 22 Nov 2022

Diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms by nuclear medicine: Update and future perspective

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xing Ma
Ying Ding
Wenliang Li
Qiang Li
Hui Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1061065

4,764 views
7 citations

Original Research

Published on 21 Nov 2022

Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jingshu Tong
Wei Jiang
Shuqi Mao
Shengdong Wu
Caide Lu

Frontiers in Oncology

doi 10.3389/fonc.2022.1040411

2,234 views
3 citations

Original Research

Published on 21 Nov 2022

Bile-volatile organic compounds in the diagnostics of pancreatic cancer and biliary obstruction: A prospective proof-of-concept study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ville Teränen
Samuli Nissinen
Antti Roine
Anne Antila
Antti Siiki
Yrjö Vaalavuo
Pekka Kumpulainen
Niku Oksala
Johanna Laukkarinen

Frontiers in Oncology

doi 10.3389/fonc.2022.918539

2,177 views
4 citations

Original Research

Published on 18 Nov 2022

A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jinbao Zhang
Meiling Chen
Chuanfa Fang
Peng Luo

Frontiers in Oncology

doi 10.3389/fonc.2022.1052132

5,014 views
9 citations

Original Research

Published on 18 Nov 2022

Comparison of laparoscopic and open pancreaticoduodenectomy for the treatment of distal cholangiocarcinoma: A propensity score matching analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuwen Zhu
Guangchen Zu
Di Wu
Yue Zhang
Yang Yang
Han Wu
Xuemin Chen
Weibo Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1057337

2,353 views
4 citations